Strains of PA. MPA strains were isolated from the sputum cultures of patients with CF seen at the Cystic Fibrosis Clinic at Yale University School of Medicine, New Haven, CT and were identified as such in the Clinical Microbiology Laboratory at Yale-New Haven Hospital. Single colonies of the strains were passed onto deoxycholate agar and stored frozen in skim milk at -70" C as well as lyophilized in skim milk. The nonmucoid variants of these strains were typed by agglutination with rabbit antisera to the seven Fisher immunotypes(l 1, 12). Strains stored by lyophilization have been demonstrated by a photographic record in our laboratory to retain mucoid morphology and immunotype characteristics for many years. We chose for this study three stable strains of three different immunotypes 1 13M (a type I), 241M (a type 6), and 256M (a type 2). Freshly reconstituted, previously lyophilized organisms were used for each phase of the study.
Patient specimens. Patient sera for the analysis of subjects with CF from Yale University School of Medicine were casual blood specimens taken from 1978 to 1985 using a protocol approved by the Human Investigation Committee. They were taken at the time of routine clinic visits and during hospitalizations for exacerbations of pulmonary disease. The sera were stored at -70" BALTIMO C until thawed for this study. Patient data were extracted from clinic charts. Throat swab or sputum culture is a routine part of all clinical visits and all potential pathogens are speciated. Length of MPA caniage was determined by review of culture reports or reported as "longer than. . ." for patients who were colonized with MPA at their first clinic visit. These patients were not included in the data analysis for correlation of length of colonization with titer of antibody.
For the blinded study of University of Iowa patients numbered specimens which had been preserved at -70" C were sent on ice. They were from patients with CF followed at least 3 yr at the University of Iowa Cystic Fibrosis Center, as well as normal subjects and adult pulmonary patients having bronchoalveolar lavage by the Pulmonary Disease Division at that institution. Bronchial washings were performed on eight patients with various diagnoses. They were clinically stable at the time of the lavage and specimens were processed as published by Merrill et al. (13) . Total protein was determined by Coomassie brilliant blue absorbance (14) and was 0.8 to 1.6 mg/ml after concentration 10-to 20-fold using positive pressure ultrafiltration (Diaflo YM5 membrane, Amicon Corp., Scientific Systems Division., Lexington, MA).
Soluble antigens. Extracts of strains 1 13M, 256M, and 24 1 M were made from 200 streaked deoxycholate agar plates incubated 24 h at 37" C. The bacterial mass was scraped off each plate into 200 ml of 0.8 M EDTA. This material was cooled and homogenized in an omnimixer for 60 s and centrifuged at 30,000 x g for 3 h. The clear supernatant (-200 ml) was dialyzed extensively at 4" C with three 10-liter bath changes against deionized water for 3 days. Carbohydrate determinations by the phenyl sulfuric acid method showed 0.2-0.5 mg/ml carbohydrate and the 256M extract which was representative of the three extracts was by weight 1 1 % carbohydrate, 39% protein, and had trace lipopolysaccharide (determined by measurement of KDO) and nucleic acid (determined by UV spectral analysis at 280 and 260 nm).
Sodium alginate which was used for sensitizing microtiter plates for testing for antibody to alginate was obtained as a purified powder from the Fisher Scientific Company and was used as a 1 % solution in deionized water.
ELISA. This assay was performed by a modification of an established technique (1 5) . The test was run in 96-well polyvinyl chloride microtiter "U" well plates (Dynatech Laboratories, Alexandria, VA). For tests of antibody to whole bacteria the strain was grown overnight on deoxycholate agar and the bacteria were suspended in PBS at an optical density of 0.600 at 750 nm. Fifty p1 of bacterial suspension were dispensed in each well and the plate was centrifuged at 1500 rpm for 5 min and then fixed with 0.25% glutaraldehyde.
For sensitization of microtiter plates with soluble extracts or with sodium alginate the optimally sensitive concentration of antigen was determined by checkerboard dilution of antigen against 2-fold dilutions of a standard rabbit antiserum to the test strain. Twenty-five p1 of diluted antigen was dispensed into each well, incubated 1 h at 37" C, blocked twice with a blocker containing 5 g of casein, 5 g bovine serum albumin, 0.1 g phenol red, and 1.8 g sodium azide per liter, washed with PBS and stored at 4" C until used for an ELISA.
When an ELISA was performed, the specimen to be tested (primary antibody) was diluted in blocker and 25 p1 of the appropriate dilution was dispensed into the well. A 2-fold dilution scheme from 1:10 to 1:327,680 was used. The plate was then incubated at room temperature at least 4 h, and the serum was aspirated from the wells. The plate was blocked, washed, with PBS and then 25 p1 of a, p, or -y chain-specific, alkaline phosphatase-conjugated goat antihuman immunoglobulin (Tago, Inc., Burlingame, CA) diluted to 1:2000 was added to the well and incubated at least 2 h at room temperature. The enzymeconjugated serum was aspirated from the wells and the plate was again washed with PBS. The test was developed by adding 50 p1 of an alkaline (pH 9.8) solution of p-nitro phenyl phosphate (1 mg/ml) in a diethanolamine buffer at room temperature for 30 min and stopping the reaction with 25 p1 of 3 N NaOH. The intensity of the color reaction was read using a Titer-Tec spectrophotometer (Flow Laboratories, McLean, VA) at 405 nm absorbance. The titer of each serum was defined as the reciprocal of the highest dilution resulting in an optical density of r 0.100 using as a negative control and internal zero standard a well in which the primary antibody is replaced by blocker.
In all tests reported, this control was colorless to the naked eye, while wells with OD 2 0.070 were obviously yellow compared with a control containing no substrate. In a separate experiment, a control without substrate was added and when the spectrophotometer was zeroed on this well; the controls without the primary antibody read < 0.2 and the test sera showed no difference in titer or OD. The positive control was an antibodycontaining normal human serum. The titer of this serum was always within a 1-to 2-fold dilution of a previously run control experiment. When the reproducibility of titering this serum (Table 3, In the absorption experiment the ELISA was performed exactly as described except the serum was preabsorbed with whole MPA (12) . The absorbed and unabsorbed portions of the serum specimen were handled identically and were tested at the same time on the same microtiter plates.
Statistical analysis. Correlation between serum titers against each pair of ELISA antigens and between titers and length of colonization was tested using the Pearson coefficient of correlation (r) using a programable calculator (Hewlett Packard HP 25). The level of significance reported was determined using Colton's (16) tables. Geometric means of the three subject groups were compared using the two-tailed t statistic for two means (17) . Differences between groups were considered to be statistically significant if p 5 0.05.
RESULTS
Antibody to MPA in the sera of CF patients and normal subjects. Tables 1-3 show the serum IgG-ELISA titers for 32 patients with CF who were colonized with MPA, eight CF patients never colonized with MPA, and 10 normal young adults.
It can be seen in Table 1 -3 that geometric mean titers for the colonized patients with CF were much higher than for the other two subject groups. The significance of this difference was determined using the two-tailed t statistic for two means and is shown in Table 4 . The colonized patients with CF had significantly more antibody to the three strains of MPA, the extracts from the three strains and to sodium alginate, compared with either the uncolonized patients or the normals. The sera of the latter two subject groups had titers that were not significantly different from each other. When IgM-ELISA titers and IgA ELISA titers were compared for these two groups, mean titers did not differ significantly using p 5 0.05 as a significance level. As shown in Table 5 , the mean titers of IgA antibody were substantially higher for the colonized CF group than for the other two groups but the spread of the titers and the size of the groups were responsible for p values greater than 0.05. The IgM titers were comparatively low in all three groups. Although a limitation on the volume of available sera was responsible for fewer subjects being tested for IgA and IgM antibody, they were a subset of the group tested for IgG antibody.
To see if duration of colonization with MPA correlated with height of the titer to any of the ELISA antigens we compared duration of colonization and IgG or IgM titer for the 23 colonized patients whose duration of colonization was known. None of the * Reciprocal of the endpoint titer. 327680 is the highest titer of the dilution series so all sera with this titer should be considered "greater than or equal to . . . ." WB, whole bacteria; EXT, extract of MPA; Na alg, sodium alginate.
t Years of colonization preceded by '5" indicates patients who were colonized at the time of diagnosis or whose records prior to anival at Y-NHH are unclear as to the earliest positive culture for MPA. $ Test not performed. * WB, whole bacteria; EXT, extract of MPA; Na alg, sodium alginate.
p values was significant (p > 0.05) in either a positive or negative trends were significant for the whole group the correlation coefdirection. ficient between titers for each pair of antigens in Table 1 was It was noted that colonized patients with CF who had a high calculated. The p values for these correlations were determined titer of antibody to one strain, extract, or to sodium alginate had and are listed in Table 6 . In general, the correlations were highly a high titer to most o r all of the antigens. Similarly, it appeared significant except that the correlation for antibody to the two that relatively low titers to one antigen was linked t o low titers other extracts (1 13M,241M) with the extract from 256M, was to most or all of them ( to sodium alginate correlated with titers to each of the whole bacteria and extracts, even though antialginate titers were considerably lower. When similar correlation determinations were calculated for the other two patient groups the strongly significant correlation between ELISA antibody titers to the different antigens, seen in the colonized patients with CF, was not present. In the group of CF patients not colonized with MPA, other than a correlation between 241M and 113M extracts ( p < 0.05) there were no significant correlations. For the normal group, other than a correlation between titers of the homologous strains and extracts, there were no significant correlations.
When a similar evaluation was done for IgM-ELISA titers there was a significant correlation in the colonized CF group between titers against each of the MPA extracts and whole bacteria except for the following: the extract of 241M and 256 whole bacteria and between sodium alginate and each of the other antigens. For the other two patient groups there were no significant correlations between titers to any of the antigens.
The correlation between IgA-ELISA titers for different antigens was similar to the IgM-ELISA titers. ELISA on sera tested "blind" to the diagnosis. Eight sera and matching BAL specimens were collected by one of us (RBF) in the University of Iowa CF Center, coded, and sent to Connecticut for testing. The objective was to see if CF patients colonized with MPA could be distinguished from patients with other diagnoses using previously obtained serum ELISA titers of the Yale patients for discrimination. The four CF patients colonized with MPA (Table 7) were correctly identified prior to breaking the code based upon two hypothesized discriminating methods predicted to have value from observation of the data on the Yale sera. 1) IgG titers to the majority of antigens within 1 SD of the mean for the group and 2) a discrimination IgG titer of 1: 10,000 for the whole bacteria and extracts distinguishing colonized CF patients from the others. As shown in Table 7 , titers in excess of 1: 10,000 were seen in all of the colonized CF patients from Iowa and only in one other subject (subject 1) to one antigen. Only three of 32 of the colonized Yale patients did not have a titer 2 1:10,000 and only one of 10 normal and one of eight noncolonized patients with CF had any titer 2 1: 10,000. ELISA on BALj7uids. IgG antibody in the BAL was seen in the colonized CF patients but there was some overlap with normals. Only patients 5 and 7 had substantially higher titers than the noncolonized subjects; however, a BAL IgG titer as high as 1:40 was seen in only one uninfected subject, to one antigen, (subject 2, to 113M whole bacteria) but a titer of r 1:40 was seen in the BAL of each of the colonized CF patients.
Although IgG serum antibody was used to predict the diagnosis in the University of Iowa samples, the serum and BAL samples were also tested for IgM and IgA anti-MPA antibodies. Serum titers were similar to the Yale patients' titers shown in Table 5 . IgM antibody in the BAL was absent by our ELISA in all subjects except patient 5 who had titers of 1:20 to 1.40 against the three whole organisms and their extracts. BAL IgA titers were similar to IgG titers but they were more clearly related to the colonization status. The normal subjects and the uncolonized CF patient had no IgA to any of the MPA antigens but all four colonized patients with CF had substantial IgA BAL titers (antiwhole 113M titers in subjects 5-8 were 1 :256, 1 :640, 1: 160, and 1: 10; titers against the other antigens were similar).
DISCUSSION
This study addresses the problem of understanding humoral immunity to MPA in patients with CF. We have demonstrated that chronically infected children and adults have high levels of broadly reactive anti-MPA antibodies, primarily of the IgG isotype. There is also substantial IgA but IgM titers are low. Only IgG titers were significantly higher in the CF patients who were * CF-col, patient with CF, colonized with mucoid PA; CF-xcol, patient with CF never colonized with PA; n, number of subjects tested; WB, whole bacteria; EXT, extract of MPA; Na alg, sodium alginate. 7 p values of the correlation coefficient are less than these numbers (two-tailed test).
$ Not significant ( p > 0.05). colonized with MPA, compared with uncolonized patients and had significantly less antibody than infected patients and had normal young adults. We have also shown that colonized patients titers not significantly greater than normal young adults who are have antibody to MPA in the bronchial-alveolar fluid. Since CF not susceptible to infection with MPA, the ELISA measures a patients who were never known to have been infected with MPA specific MPA-induced IgG immune response. This assumption BALTIMOI was tested on a small collection of specimens from the University of Iowa and the four patients with CF who were colonized with MPA were identified of the eight subjects on the basis of the serum IgG titers against MPA. While the majority of these patients clearly fell in one group or the other based upon review of the data from the patients at Yale there were still some individual patients whose titers were in between. Thus from the set of patients from Iowa, subjects 1 and 7 (Table 7) had titers which were not very different and three of the colonized patients from Yale had serum titers which were not higher than many of the normal subjects.
Pier et al. (8) , Speert et al. (9) , and Bryan et al. (10) have previously shown that infected patients with CF have high titers of antibody to the mucoid exopolysaccharide of MPA but they tested purified extracts from one strain. Speert et al. (9) also showed that these patients have serum immunoreactivity to sodium alginate but in contrast to our study their results showed that the titer correlated with length of chronic infection. Most of our patients had a long duration of colonization and it is quite possible that antibody rises to a certain titer and then plateaus. A prospective study with samples taken at short intervals might give different results. Using a statistical analysis we have demonstrated that the titer of immunoreactivity to sodium alginate is correlated with the titer to the whole organism and an extract of three strains, each with a different immunotype (primarily lipopolysaccharide) antigen. Absorption of sera with one of the strains reduced the IgG and IgM titer to the whole cells and extracts of the other two. While the titers were not reduced to zero, it appears that most of the anti-MPA immunoreactivity in the normal sera and serum from an infected subject was directed toward a shared antigen or antigens. These results are consistent with the hypothesis that while chronically infected patients with CF develop antibody to a lipopolysaccharide antigen (1 8) a major part of the antibody response is to a common antigenic determinant or determinants which is not the lipopolysaccharide antigen. If the antibody response was to the immunotype or lipopolysaccharide antigen, infected patients would have antibody measurable to one immunotype but not the others and absorption should only remove antibody to strains having the same immunotype as the absorption strain. Such a response is seen with infections due to nonmucoid strains of PA (19) . The finding of anti-Pseudomonas antibody in the BAL, primarily of the IgG and IgA isotype, is intriguing. It was demonstrated by Schicdtz et al. (20) , using an immunofluorescence assay, that colonized patients with CF have anti-Pseudomonas antibody in the sputum, while uncolonized patients do not. The data presented herein on a small number of patients show that this is also true of the BAL and the titers appear to parallel the serum antibody titer for IgG, IgA, and IgM. The in vivo function of this antibody is unknown since MPA are generally never completely cleared from the lungs. Among the factors that may be responsible for this failure are the proposed defective function of antibody to MPA in patients with CF (18), leukocyte and pseudomonas IgG protease in CF sputum (2 I), and relative resistance of MPA to binding opsonophagocytic antibody (12) .
The results of this study may have implications for research efforts aimed at the development of an anti-MPA vaccine. Pseudomonas vaccines have been effective for patients with burns in which an LPS extract is used and multivalent vaccines are required for protection (22), but no human trials of an MPA or alginate vaccine have, as yet, been reported. This study does not address the question of whether antibody to a shared antigen such as the alginate exopolysaccharide would be protective against the effects of infection or if it would prevent colonization, but these data do suggest that a response to such antigens exists in chronically infected patients. One interesting finding of this study in terms of possible vaccine strategy is that anti-MPA antibody is found in the lung, albeit in low titer relative to the serum. It is not clear if this antibody represents exuded serum antibody or endogenous pulmonary production of antibody. The presence of this antibody, however, demonstrates the potential for local airway immunity in individuals who possess systemic humoral immunity.
